1)国立がん研究センターがん情報サービス:地域がん登録全国推計によるがん罹患データ(1975年〜2013年).http://ganjoho.jp/reg_stat/statistics/dl/index.html#incidence
2)厚生労働省:平成22年国民生活基礎調査の概況.http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa10/index.html
3)Gøtzsche PC, et al:Cochrane Database of Systematic Reviews, Issue 1, Art. No.CD001877, 2011
4)Hewitson P, et al:Cochrane Database of Systematic Reviews, Issue 1, Art. No.CD001216, 2007
5)Alberle DR, et al:Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409, 2011
6)Schröder FH, et al:Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320-1328, 2009
7)Andriole GL, et al:Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310-1319, 2009
8)国立がん研究センター社会と健康研究センター:有効性評価に基づく胃がん検診ガイドライン2014年版.http://canscreen.ncc.go.jp/guideline/igan.html
9)Welch HG, et al:Overdiagnosis in cancer. J Natl Cancer Inst 102:605-613, 2010
10)Zlotta AR, et al:Prevalence of prostate cancer on autopsy:cross-sectional study on unscreened Caucasian and Asian men. J Natl Cancer Inst 105:1050-1058, 2013
11)Wilt TJ, et al:Screening for cancer:advice for high-value care from the American College of Physicians. Ann Intern Med 162:718-725, 2015
12)Lee SJ, et al:Time lag to benefit after screening for breast and colorectal cancer:meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 346:e8441, 2013